Baxter International (BSP:B1AX34) Cyclically Adjusted Revenue per Share: R$67.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:B1AX34 Baxter International Inc BSP:B1AX34
59 GF Score
Price R$59.46
GF Value R$90.49
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Baxter International Cyclically Adjusted Revenue per Share?

Baxter International BSP:B1AX34 +8.80% 59 Cyclically Adjusted Revenue per Share is R$67.02 as of Mar. 2026. GuruFocus rates BSP:B1AX34 with a GF Score™ of 59/100 and a GF Value™ of R$90.49 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Baxter International's adjusted revenue per share for the three months ended in Mar. 2026 was R$13.714. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$67.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Baxter International's average Cyclically Adjusted Revenue Growth Rate was 2.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Baxter International was 7.50% per year. The lowest was -4.00% per year. And the median was 1.40% per year.

As of today (2026-07-18), Baxter International's current stock price is R$59.46. Baxter International's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$67.02. Baxter International's Cyclically Adjusted PS Ratio of today is 0.89.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Baxter International was 4.06. The lowest was 0.63. And the median was 2.68.


Baxter International  (BSP:B1AX34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Baxter International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=59.46/67.02
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Baxter International was 4.06. The lowest was 0.63. And the median was 2.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Baxter International Cyclically Adjusted Revenue per Share Related Terms


Baxter International Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Baxter International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Cyclically Adjusted Revenue per Share Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.33 64.18 62.14 76.30 70.43

Baxter International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.11 68.22 65.76 70.43 67.02

BSP:B1AX34 vs ALGN, SOLV, COO: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Baxter International's Cyclically Adjusted PS Ratio falls into.


BSP:B1AX34
59GF Score
Baxter International Inc BSP:B1AX34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Baxter International's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=13.714/330.2130*330.2130
=13.714

Current CPI (Mar. 2026) = 330.2130.

Baxter International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 8.001 241.018 10.962
201609 7.551 241.428 10.328
201612 8.094 241.432 11.070
201703 7.024 243.801 9.514
201706 7.734 244.955 10.426
201709 7.612 246.819 10.184
201712 8.258 246.524 11.061
201803 7.965 249.554 10.539
201806 9.796 251.989 12.837
201809 10.388 252.439 13.588
201812 10.187 251.233 13.389
201903 9.705 254.202 12.607
201906 10.527 256.143 13.571
201909 11.293 256.759 14.524
201912 12.087 256.974 15.532
202003 13.267 258.115 16.973
202006 13.638 257.797 17.469
202009 15.491 260.280 19.653
202012 15.827 260.474 20.065
202103 16.244 264.877 20.251
202106 15.303 271.696 18.599
202109 16.828 274.310 20.257
202112 16.102 278.802 19.071
202203 18.121 287.504 20.813
202206 17.856 296.311 19.899
202209 18.774 296.808 20.887
202212 -3.642 296.797 -4.052
202303 18.117 301.836 19.820
202306 17.779 305.109 19.242
202309 12.609 307.789 13.528
202312 12.993 306.746 13.987
202403 12.157 312.332 12.853
202406 14.198 314.175 14.923
202409 14.596 315.301 15.286
202412 16.370 315.605 17.128
202503 14.703 319.799 15.182
202506 15.159 322.561 15.519
202509 14.790 324.800 15.036
202512 15.814 324.054 16.115
202603 13.714 330.213 13.714

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$67.02 mean?
Baxter International (BSP:B1AX34) has a Cyclically Adjusted Revenue per Share of R$67.02 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Baxter International and its competitors.
Is Baxter International's Cyclically Adjusted Revenue per Share too high?
Baxter International's current Cyclically Adjusted Revenue per Share is R$67.02. Overall, Baxter International has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Cyclically Adjusted Revenue per Share compare to ALGN and SOLV?
Baxter International's Cyclically Adjusted Revenue per Share of R$67.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Baxter International and its competitors. Baxter International's current Cyclically Adjusted Revenue per Share is R$67.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BSP:B1AX34) is currently considered Possible Value Trap. The stock's GF Value™ is R$90.49, compared to a current price of R$59.46 — trading 34.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$67.02. Baxter International's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Baxter International (BSP:B1AX34), the current Cyclically Adjusted Revenue per Share is R$67.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (BSP:B1AX34) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of R$59.46 is trading 34.3% below its estimated GF Value™ of R$90.49. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for BSP:B1AX34:

  • Cyclically Adjusted Revenue per Share: R$67.02
  • GF Value™: R$90.49 vs. price of R$59.46 (34.3% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the BSP:B1AX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
59GF Score

Get the complete analysis for BSP:B1AX34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$59.46
Price
R$90.49
GF Value